Login

KUBOTA PHARMACEUTICAL HOLDINGS CO LTD 3 SEC Filings

Filed On Filing
08 Mar 2017 Form 3: Sbi Incubation Co., Ltd., 10% owner

Holds 8,289,756 shares of Common Stock

01 Sep 2015 Form 3: Girard Roger, Chief Strategy Officer

Holds 0 shares of Common Stock

26 Aug 2015 Form 3: Lasezkay George M, EVP of Legal Affairs

Holds 0 shares of Common Stock

19 Aug 2015 Form 3: Scheibler Lukas, EVP of Translational Medicine

Holds 0 shares of Common Stock

29 Jul 2015 Form 3: Asako Shintaro, Director

Holds 800 shares of Common Stock

17 Jun 2015 Form 3
11 May 2015 Form 3: Takeuchi Robert, Director

Holds 0 shares of Common Stock

11 May 2015 Form 3: Kitao Yoshitaka, Director

Holds 204,800 shares of Common Stock

05 May 2015 Form 3: Tarr Steven C, Chief Operating Officer

Holds 0 shares of Common Stock

05 May 2015 Form 3: Danse Edward H, Chief Business Officer

Holds 0 shares of Common Stock

05 May 2015 Form 3: Gebhart John E, Chief Financial Officer

Holds 0 shares of Common Stock

05 May 2015 Form 3: Nakamura Eisaku, Director

Holds 800 shares of Common Stock

05 May 2015 Form 3: Mita Shiro, Director

Holds 200 shares of Common Stock

26 Mar 2015 Form 3: Blocker Dewey H. Jr., VICE PRESIDENT FINANCE

Holds 0 shares of Common Stock

03 Feb 2014 Form 3: Schutzler Michael, Director

Holds 0 shares of Common Stock

03 Feb 2014 Form 3: Sato Glen Y, Director

Holds 0 shares of Common Stock

03 Feb 2014 Form 3: O'callaghan Brian, Director

Holds 0 shares of Common Stock

03 Feb 2014 Form 3: Lowrance David L, CFO, Secretary, Treasurer

Holds 0 shares of Common Stock

03 Feb 2014 Form 3: Kubota Ryo, Director

Holds 11,620,654 shares of Common Stock

03 Feb 2014 Form 3: Kresel Peter, Director

Holds 0 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support